Walker B R, Williamson P M, Brown M A, Honour J W, Edwards C R, Whitworth J A
Department of Medicine, University of Edinburgh, Western General Hospital, Scotland, UK.
Hypertension. 1995 Apr;25(4 Pt 1):626-30. doi: 10.1161/01.hyp.25.4.626.
Preeclampsia is accompanied by amplification of the sodium retention that is a feature of normal pregnancy. Recent evidence suggests that mineralocorticoid receptor activation is increased in preeclampsia, but classic mineralocorticoids (aldosterone, 11-deoxycorticosterone) are not present in excess. Cortisol can act as a mineralocorticoid receptor agonist only when its renal inactivation to cortisone by 11 beta-hydroxy-steroid dehydrogenase is impaired, for example, in congenital enzyme deficiency and after administration of exogenous inhibitors (eg, licorice). Endogenous inhibitors of this enzyme have been detected in human urine and are increased in pregnancy. To establish whether cortisol causes mineralocorticoid excess in hypertensive pregnancy and whether endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase are responsible, we studied 25 hypertensive pregnant patients (13 with preeclampsia and 12 with gestational hypertension), 16 normotensive pregnant subjects, and 13 nonpregnant control subjects. Concentrations of plasma renin and aldosterone were increased in pregnancy, but less so in hypertensive pregnancy. Plasma potassium and urinary electrolytes were not different between the groups. Plasma cortisol was increased in pregnancy but not different in hypertensive pregnancy, and urinary cortisol, plasma and urinary cortisone, and urinary tetrahydrocortisol and tetrahydrocortisone were not different between the groups. Endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase were more active in urine from pregnant women but were not increased further in hypertensive pregnancy. There were no differences in these parameters between patients with preeclampsia and gestational hypertension. We conclude that deficient inactivation of cortisol to cortisone does not contribute to the sodium retention of normotensive or hypertensive pregnancy and that endogenous inhibitors of 11 beta-hydroxysteroid dehydrogenase have no evident pathophysiological significance in pregnancy.
子痫前期伴随着钠潴留的增强,而钠潴留是正常妊娠的一个特征。最近的证据表明,子痫前期中盐皮质激素受体的激活增加,但经典的盐皮质激素(醛固酮、11-脱氧皮质酮)并无过量。只有当皮质醇经11β-羟类固醇脱氢酶使其在肾脏失活转化为可的松的过程受损时,皮质醇才能作为盐皮质激素受体激动剂,例如在先天性酶缺乏以及给予外源性抑制剂(如甘草)之后。这种酶的内源性抑制剂已在人尿中被检测到,且在妊娠时增加。为了确定皮质醇是否导致高血压妊娠中盐皮质激素过量,以及11β-羟类固醇脱氢酶的内源性抑制剂是否起作用,我们研究了25例高血压孕妇(13例子痫前期患者和12例妊娠期高血压患者)、16例血压正常的孕妇以及13例非孕对照者。妊娠时血浆肾素和醛固酮浓度升高,但在高血压妊娠中升高程度较小。各组间血浆钾和尿电解质无差异。妊娠时血浆皮质醇升高,但高血压妊娠时无差异,且各组间尿皮质醇、血浆和尿可的松以及尿四氢皮质醇和四氢可的松无差异。11β-羟类固醇脱氢酶的内源性抑制剂在孕妇尿中活性更高,但在高血压妊娠中未进一步增加。子痫前期患者和妊娠期高血压患者在这些参数上无差异。我们得出结论,皮质醇转化为可的松的失活不足并非导致血压正常或高血压妊娠中钠潴留的原因,且11β-羟类固醇脱氢酶的内源性抑制剂在妊娠中无明显的病理生理意义。